S140: IBRUTINIB SENSITIZES CLL CELLS TO VENETOCLAX BY INTERRUPTING TLR9-INDUCED CD40 UPREGULATION AND PROTEIN TRANSLATION

• Karoline Kielbassa,
• Marco Haselager,
• Danique Bax,
• Bianca van Driel,
• Mark-David Levin,
• Sabina Kersting,
• Rebecka Svanberg,
• Carsten U. Niemann,
• Arnon P. Kater,
• Eric Eldering

Affiliations

Karoline Kielbassa

1 Departments of Experimental Immunology and Hematology, Amsterdam UMC, University of Amsterdam

Marco Haselager

1 Departments of Experimental Immunology and Hematology, Amsterdam UMC, University of Amsterdam

Danique Bax

1 Departments of Experimental Immunology and Hematology, Amsterdam UMC, University of Amsterdam

Bianca van Driel

1 Departments of Experimental Immunology and Hematology, Amsterdam UMC, University of Amsterdam

Mark-David Levin

2 Department of Internal Medicine, Albert Schweitzer hospital, Dordrecht

Sabina Kersting

3 Haga Teaching Hospital, Den Haag, The Netherlands

Rebecka Svanberg

4 Rigshospitalet, Department of Hematology, Copenhagen, Denmark

Carsten U. Niemann

4 Rigshospitalet, Department of Hematology, Copenhagen, Denmark

Arnon P. Kater

1 Departments of Experimental Immunology and Hematology, Amsterdam UMC, University of Amsterdam

Eric Eldering

1 Departments of Experimental Immunology and Hematology, Amsterdam UMC, University of Amsterdam